Novo Nordisk Surges After Early Trial Shows Promise of New Obesity Drug




Shares hit a record after the Danish pharmaceutical giant said the drug could be more effective than blockbuster Wegovy.




Shares hit a record after the Danish pharmaceutical giant said the drug could be more effective than blockbuster Wegovy.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@technoblender.com. The content will be deleted within 24 hours.
DrugEarlyEconomyMarketNordiskNovoobesitypromiseShowssurgesTechnoblenderTrial
Comments (0)
Add Comment